The Tri-Service General Hospital is a medical center in Neihu District, Taipei, Taiwan. It is the teaching hospital of the National Defense Medical Center.

During the past decade, Tri-Service General Hospital; Hematology and Oncology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tri-Service General Hospital; Hematology and Oncology" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Tri-Service General Hospital; Hematology and Oncology" are "Breast Cancer" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Tri-Service General Hospital; Hematology and Oncology" in a lesser frequency.

Most popular intervention types in "Tri-Service General Hospital; Hematology and Oncology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (1 trials), "Chemotherapy" (1 trials), "docetaxel" (1 trials), "paclitaxel" (1 trials) and "pertuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tri-Service General Hospital; Hematology and Oncology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Tri-Service General Hospital; Hematology and Oncology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Tri-Service General Hospital; Hematology and Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tri-Service General Hospital; Hematology and Oncology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".